DCF — MERCY MEDICAL CENTER
Enterprise Value: $-792.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-792.3M
Enterprise Value
$-247.9M
PV of Cash Flows
$-544.4M
PV of Terminal Value
$-876.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $413.1M | $-50.9M | -12.0% | $-68.4M | $-62.1M |
| Year 2 | $425.5M | $-48.1M | -11.0% | $-66.2M | $-54.7M |
| Year 3 | $438.2M | $-45.2M | -10.0% | $-63.8M | $-47.9M |
| Year 4 | $451.4M | $-44.3M | -10.0% | $-63.4M | $-43.3M |
| Year 5 | $464.9M | $-44.5M | -10.0% | $-64.2M | $-39.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-792.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$401.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.12815884026460078
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5